2024-09-16 - Analysis Report
## ISRG Stock Analysis Report

**Company Overview:**  Intuitive Surgical, Inc. (ISRG) is a medical device company that designs, manufactures, and sells surgical systems and instruments.

**1. Performance Relative to S&P 500 (VOO):**

* **Cumulative Return:** ISRG has a cumulative return of 103.25%, while VOO has a cumulative return of 88.73%.
* **Outperformance:** ISRG has outperformed VOO by 14.52% (absolute) and 60.41% (relative).  This means ISRG has outperformed VOO by a significant margin, considering its historical performance.

**2. Recent Price Movements:**

* **Closing Price:** $489.86
* **Moving Averages:** 
    * 5-Day: $487.69
    * 20-Day: $484.22
    * 60-Day: $458.61

The stock price is currently above all three moving averages, indicating a positive trend. The 5-day moving average is very close to the closing price, suggesting potential short-term stability.

**3. Technical Indicators:**

* **RSI:** 52.43 - This indicates that the stock is neither overbought nor oversold, suggesting a neutral sentiment.
* **PPO:** -0.14 - A negative PPO value suggests a potential bearish trend, although it is not significant.
* **Delta_Previous_Relative_Divergence:** 0.55 - A positive value indicates that the stock's recent relative strength is increasing, suggesting a potential short-term upside.
* **Expected_Return:** 16.94% - This indicates a potential 5-year return of 16.94%, which is a positive indicator.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-07-24 | 1.2 | 1.76 B$ |
| 2024-07-19 | 1.2 | 1.76 B$ |

**Analysis:** 

* The latest earnings report for Q2 2024 (July 19th) showed a significant increase in both EPS and revenue compared to the previous quarter, exceeding analyst expectations. 
* This growth indicates positive trends in the company's operations and strong demand for its products.
* The company's focus on innovation and expanding its surgical portfolio is expected to drive further growth.

**5. Overall Analysis:**

* ISRG has consistently outperformed the market (VOO) with a significant return.
* Technical indicators suggest a neutral to bullish sentiment, with potential for short-term upside.
* Strong recent earnings results and a positive outlook for the company further reinforce its growth potential.

**Conclusion:**

Based on the analysis, ISRG appears to be a promising investment with a solid track record of outperformance.  The positive technical indicators and strong recent earnings results suggest a continued upward trend, making it a worthwhile investment for those seeking exposure to the medical device sector. However, it is important to remember that all investments carry risk, and investors should conduct their own due diligence before making any investment decisions. 
